Evidence map›Paper›PMID 35515355›Full record

ArticleBreast cancer (Dove Medical Press)2022

Breast Cancer in Italy: Stage and Region Distribution.

Lucia Mangone, Isabella Bisceglia, Maria Michiara, Antonino Musolino, Guido Mazzoleni, Adele Caldarella, Sante Minerba, Giuseppe Cascone, Francesca Bella, Ylenia Dinaro and 2 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer (Dove Medical Press), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Lucia MangoneEpidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Isabella BiscegliaEpidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Maria MichiaraMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Antonino MusolinoMedical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Guido MazzoleniPathology Service South Tyrol Local Health Authority, Bolzano, 39100, Italy.
Adele CaldarellaTuscany Cancer Registry, Clinical and Descriptive Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Sante MinerbaLocal Health Service Taranto, Taranto, Italy.
Giuseppe CasconeCancer Registry, Provincial Health Department, Ragusa, Italy.
Francesca BellaSiracusa Cancer Registry, Azienda Sanitaria Provinciale Di Siracusa, Siracusa, Italy.
Ylenia DinaroSiracusa Cancer Registry, Azienda Sanitaria Provinciale Di Siracusa, Siracusa, Italy.
Loredana PauEuropa Donna, Italia, Milan, Italy.
Carmine PintoMedical Oncology Unit, Comprehensive Cancer Centre, Azienda Unità Sanitaria Locale -IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Azienda Sanitaria Unità Locale di Reggio Emilia · ITAgenzia Regionale Sanitaria della Puglia · ITUniversity of Parma · ITEuropa Donna · ITOspedale di Bolzano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Describe breast cancer in Italy by age, geographical area, stage and sites of metastases. In addition, incident and prevalent cases by region are provided. Patients and Methods: This population-based study included all female patients with histologically confirmed breast cancer diagnosed in Italy between 2013 and 2019 in the eight participating Cancer Registries. Cases were described by geographic area (north, center, south), age group (<50, 50-69 and 70+) and site of metastases. In addition, the study also provided an estimate of the cases of metastatic breast cancer per single region. Results: Of the total 5731 cases, the number of unknown stage cases (eliminated from our analyses) was 545 (10.5% of cases); therefore, the study was conducted on 5186 cases. Overall, 333 (6.5%) of tumors were metastatic at diagnosis but the distribution by geographical area was different: 5.1% in the north, 7.4% in the center and 7.8% in the south. Related to age, 5.6% were diagnosed before the age of 50 and 5.6% within the screening target group (50-69 years), while in elderly women the percentage rose to 8.1%. As regards the site of the metastases, 27.1% developed metastasis to the bone, 12.4% to the liver, 8.6% to the lung and 2.6% to the brain; in 34.9%, multiple sites were already present at the beginning of the cancer. Overall, 3520 cases of incident mBC are estimated in Italia every year (520 in Lombardy in northern Italy, 350 in Lazio in the center, followed by 330 in Campania in the south), and finally they are out of 52,000 prevalent cases. Conclusion: A greater possibility of treating and living with the disease for a long time now requires careful monitoring of these tumors.

Indexed as

breast cancerincidenceItalymetastatic

Identifiers

PMID35515355
PMCPMC9064450
OpenAlexW4225122572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.